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To the Editor: With interest, we read the article by Yu et al.[1] about 
the clinical presentation and central nervous system (CNS) imaging 
in 19 patients with Kearns-Sayre syndrome (KSS), of whom 12 
were genetically confirmed. We have the following comments 
and concerns.
The main disadvantage of the study was that the diagnosis was 
not genetically confirmed in all patients and mitochondrial DNA 
(mtDNA) deletion was detected in only 63% patients.[1] What was 
the reason for seven KSS patients not undergoing genetic testing? 
Did not all patients undergo muscle biopsy?
If only 12 of 19 patients underwent muscle biopsy, how can KSS 
be diagnosed? Among the seven patients who obviously did not 
undergo muscle biopsy, upon which clinical criteria were these 
patients diagnosed as KSS?
Among the seven patients who were not genetically confirmed, 
did the authors look for mtDNA point mutations in lymphocytes? 
It has been repeatedly reported that KSS may not only be due 
to mtDNA deletions but also due to mtDNA point mutations, 
such as m.3249G>A in the tRNA (Leu) gene, m.3255G>A in the 
tRNA (Leu) gene, or m.3243A>G in the tRNA (Leu) gene.
We should also be informed about the results of biochemical 
investigations to know about the activity of respiratory chain 
complexes. Complex I, complex II, complex IV, complex I and IV, 
complex I, III, and IV, complex I, IV, and V, and complex I, III, 
IV, and V deficiency or normal respiratory chain activity has been 
previously described in KSS.[2,3]
Among the 15 patients who underwent cerebral magnetic resonance 
imaging, six patients showed hyperintensities on diffusion-weighted 
imaging in the white matter or basal ganglia.[1] We should be 
informed about the nature and pathogenesis of these lesions. Were 
these lesions on the corresponding apparent diffusion coefficient 
map hyper-, hypo-, or iso-intense? Were these lesions interpreted 
as cytotoxic edema or as vasogenic edema? Can these lesions be 
interpreted as stroke-like lesions, the morphological correlate of 
a stroke-like episode?
Cognitive functions can be impaired in KSS patients.[4] Did the 
19 patients also undergo neuropsychological testing to assess their 
cognitive abilities and if they were impaired or not?
Did the authors consider implantation of an implantable 
cardioverter defibrillator in any of their patients since four patients 
died from sudden cardiac death in a series of 35 KSS patients?[4] 
Did the patients undergo long‑term electrocardiogram recordings, 
and in particular were loop recorders implanted to see if any of the 
patients had a tendency to develop prolonged QT-interval, early 
repolarization, or ventricular arrhythmias?
It was interesting to see that only 3 of 19 had short stature.[1] Short 
stature is one of the clinical criteria for diagnosing KSS.[5]
Overall, these interesting case series should be supplemented by 
more detailed clinical, instrumental, and genetic data. The more 
information about KSS patients is collected, the more we can learn 
about the phenotypic and genotypic variability of these patients, and 
the better will be the management and outcome of KSS patients.
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We appreciate the readers’ interest and their comprehensive 
comments and advice about the article,[1] which mainly concerned 
details of the patients’ information.
In this paper, we reported 19 Kearns‑Sayre syndrome (KSS) patients 
whose diagnoses were in accordance with the current clinical 
diagnostic criteria of KSS, i.e., the triad of progressive external 
ophthalmoplegia, pigmentary retinopathy, and onset before 20 years 
of age, plus at least one of the followings: heart block, cerebellar 
symptoms, or cerebrospinal fluid protein levels above 1000 mg/L.[2] 
The diagnostic criteria have been widely used.[3] Apart from clinical 
features, muscle pathology and molecular genetic analysis can 
play a great role in the diagnostic workup. Muscle pathology 
showed ragged‑red fibers (RRF), ragged‑blue fibers (RBF), or 
cytochrome c‑oxidase (COX)‑negative fibers in almost all patients.[4] 
Southern blot or long‑range polymerase chain reaction can detect 
single large‑scale deletion in about 90% of KSS patients,[5] while 
mitochondrial DNA (mtDNA) point mutations or nuclear gene 
mutations have been reported in other KSS patients.[6] In general, 
single large‑scale deletion can be detected only from the muscle, 
but not from blood cells of KSS patients.[7] Among the 19 patients 
reported by us, 15 patients underwent muscle biopsy in our hospital 
which showed RRF, RBF, and COX‑negative fibers in all of them; 
however, mtDNA mutation detection was available in 11 of them 
because muscle tissue of the other four (patients 8, 10, 17, and 18) 
were not enough for further gene analyses; one patient (patient 12) 
had muscle biopsy in another hospital, and we got a little muscle 
tissue to do the mutation examination although RBF% cannot be 
counted. Three patients (patients 2, 5, and 7) refused to receive 
muscle biopsy, but all of them showed typical KSS features. We 
performed common mtDNA point mutations analysis (mtDNA 
A3243G, A8344G) in their blood, which were negative.
Biochemical investigations, especially activity assay of respiratory 
chain complexes in muscle tissues, can also help provide evidence 
for the diagnosis of mitochondrial disease.[8] Unfortunately, such 
a detecting platform has not been established in our laboratory.
There were several articles studying the exact nature of high 
signal lesions on diffusion‑weighted imaging (DWI) in patients 
with mitochondrial diseases, especially mitochondrial myopathy, 
encephalopathy, lactic acidosis, and stroke‑like episodes. However, 
the results were conflicting since some reported an increase 
in the apparent diffusion coefficient (ADC) values suggesting 
vasogenic edema while others described a decrease in the ADC 
values reflecting cytotoxic edema.[9] In our KSS patients, we also 
found the same interesting phenomena that the ADC values of 
the regions with high signal on DWI were not consistent. Some 
patients showed increased ADC values while the others showed 
decreased ADC values. We proposed that the discrepancy might be 
due to the different disease stages in different individual patients 
although further studies are needed to elucidate the underlying 
pathophysiological mechanism.
The results of Moraes et al.[2] showed cognitive decline in 31% of 
KSS patients, which was associated with the presence of disability. 
In our research, the present study was mainly focused on the 
electrocardiogram and brain magnetic resonance imaging changes 
of the patients. Cognitive function was only evaluated in one patient, 
which also showed a moderate decline of cognitive function.
In our research, all the patients underwent Holter monitoring, and 
as we reported in the article, none of them developed ventricular 
arrhythmias, which was also a big difference from previous 
reports. Therefore, the cardiologists did not suggest implantable 
cardioverter defibrillator implantation in these patients.
According to the height and weight standardized growth charts for 
Chinese children and adolescents aged 0–18 years,[10] we only found 
the heights of three patients more than two standard deviations 
below the mean for age and gender. The heights of other six patients 
were below the mean height for age and gender but did not reach 
the definition for short stature.
Again, we show our greatest thanks for the comments and advices, 
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